300 results on '"D’Arminio Monforte, A."'
Search Results
2. Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men
3. Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study
4. Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis – results from the ICONA cohort in Italy, 2009-2022
5. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
6. Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohort
7. SARS-CoV-2 and the nervous system: review on pathogenesis of nervous system SARS-CoV-2 damage
8. Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries
9. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
10. Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts
11. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis
12. Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network
13. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration
14. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis
15. Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort
16. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
17. Pillars of long-term antiretroviral therapy success
18. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
19. Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis
20. Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
21. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
22. HIV-Indicator Condition Guided Testing in a Hospital Setting
23. HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
24. Differences in clinical characteristics and quantitative lung CT features between vaccinated and not vaccinated hospitalized COVID-19 patients in Italy
25. The presence of resistance‐associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV‐1 escape: A multicentric retrospective analysis
26. Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
27. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
28. Mpox in people with advanced HIV infection: a global case series
29. Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
30. Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
31. Monkeypox epidemic in prisons: How to prevent it?
32. Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
33. Management of Chronic Hepatitis B in HIV-Coinfected Patients
34. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV
35. Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects
36. The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis
37. HIV‐NAAT use for early detection of HIV infection among high‐risk men who have sex with men in Italy
38. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium
39. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
40. MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection
41. Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American immigrants in Italy – The CHILI study
42. One‐year cognitive follow‐up of COVID‐19 hospitalized patients
43. Hepatitis Delta in HIV: changes in attitude to testing and disease burden over time
44. Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects
45. Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)
46. Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process
47. Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice
48. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium
49. Prolonged cognitive deficits after COVID-19
50. Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific Patterns
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.